skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine (Code C115105)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine

Definition: A dendritic cell (DC)-based cancer vaccine composed of autologous dendritic cells (DCs) activated with an ovarian tumor cell lysate containing tumor-associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, the ovarian tumor antigen-activated autologous DC vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells expressing ovarian tumor cell-specific antigens, which may result in ovarian tumor cell lysis.

Label: Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine

NCI Thesaurus Code: C115105 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL472636  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
DCVAC/OvCa
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 759856
PDQ Open Trial Search ID 759856 (check for NCI PDQ open clinical trial info)
NCI META CUI CL472636

Other Properties:
     Name Value (qualifiers indented underneath)
code C115105
Semantic_Type Cell
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C115105

Mainbox Bottom